Ikonisys S.A. (ALIKO.PA)
| Previous close | 1.4600 |
| Open | 1.4600 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 1.4600 - 1.4700 |
| 52-week range | 1.1400 - 1.8000 |
| Volume | |
| Avg. volume | 6,331 |
| Market cap | 15.364M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Ikonisys Introduces New Website to Highlight Advantages of FISH Technology and Total Automation in Healthcare
PARIS, May 30, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, is proud to announce the launch of its new website, dedicated to raising awareness of Fluorescence In Situ Hybridization (FISH) technology and its applications in mass screening programs within the healthcare sector.
- Business Wire
Ikonisys Announces Postponement of the Publication of Its 2023 Annual Financial Report
PARIS, May 24, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, announces that the publication of its 2023 annual financial report will be further postponed and will be published by June 28, 2024.
- Business Wire
Ikonisys: Hospitex Expands in Ukraine through a Partnership with Diagen LLC to Fight Cancer
PARIS, May 21, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces that Hospitex has signed a new distribution partnership in Ukraine with Diagen LLC, a leading Ukrainian distributor and laboratory services provider. This collaboration aims at reinforcing the Company’s commitment to the global fight against cancer.
